Medicare_Claims_Processing_Manual / 4032

Why This Topic Matters

It helps readers understand a Medicare manual update that affects how outpatient E/M services are reported alongside certain drug administration encounters, and it clarifies who qualifies as a new patient under the manual’s framework.

Article Sections

1. Summary of Changes

   Overview of the manual update, including the general policy areas addressed and the timing of the changes.

2. General Information

   Background and policy context for the revision, including the areas of the manual being clarified and the broad categories of service affected.

3. Business Requirements

   Administrative implementation content related to the transmittal.

4. Provider Education

   Education-related implementation content associated with the update.

5. Supporting Information and Possible Design Considerations

   Operational and systems-support material, including dependencies, interfaces, and testing considerations.

6. Schedule, Contacts, and Funding

   Effective and implementation dates, contact information, and funding notes for the transmittal.

7. Payment for Office or Other Outpatient Evaluation and Management (E/M) Visits

   Manual text for the revised outpatient E/M policy, including patient definitions, same-day visit considerations, admission-day guidance, and drug administration-related billing policy.

8. Definition of New Patient for Selection of E/M Visit Code

   Criteria used within the manual to define new patient status for office and outpatient E/M code selection.

9. Office/Outpatient E/M Visits Provided on Same Day for Unrelated Problems

   General policy for multiple office or outpatient E/M encounters on the same date of service.

10. Office/Outpatient or Emergency Department E/M Visit on Day of Admission to Nursing Facility

    Policy language addressing E/M services on the date of nursing facility admission.

11. Drug Administration Services and E/M Visits Billed on Same Day of Service

    Policy language addressing same-day E/M and drug administration reporting, including documentation and modifier-related guidance.